Area of research
Genetics · Psychiatry and Mental health
Research interest
Research interests include Genetic Associations and Epidemiology, Dementia and Cognitive Impairment Research, Pharmacogenetics and Drug Metabolism, and Alzheimer's disease research and treatments.
Clinical and Imaging Markers of Cardiac Function and Brain Health
Whole genome sequencing analysis of body mass index identifies novel African ancestry-specific risk allele
A Large-Scale Genome-wide Association Study of Blood Pressure Accounting for Gene-Depressive Symptomatology Interactions in 564,680 Individuals from Diverse Populations
Association Between Acute Myocardial Infarction and Cognition
Serum NfL and GFAP are associated with incident dementia and dementia mortality in older adults: The cardiovascular health study
Identification of circulating proteins associated with general cognitive function among middle-aged and older adults
Genome-wide association analyses of physical activity and sedentary behavior provide insights into underlying mechanisms and roles in disease prevention
Meta-analysis of genome-wide association studies identifies ancestry-specific associations underlying circulating total tau levels
Proteomics and Population Biology in the Cardiovascular Health Study (CHS): design of a study with mentored access and active data sharing
Association of Serum Neurofilament Light Chain Concentration and MRI Findings in Older Adults:The Cardiovascular Health Study
EUR Research Repository (Erasmus University Rotterdam) 2022cited by 21position: first
Genome-wide meta-analyses reveal novel loci for verbal short-term memory and learning
Genome-wide meta-analysis of muscle weakness identifies 15 susceptibility loci in older men and women
Advancing precision public health using human genomics: examples from the field and future research opportunities
Pre-Statistical Considerations for Harmonization of Cognitive Instruments: Harmonization of ARIC, CARDIA, CHS, FHS, MESA, and NOMAS
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for <i>CYP2C9</i> and <i>HLA‐B</i> Genotypes and Phenytoin Dosing: 2020 Update
Assessing the clinical impact of CYP2C9 pharmacogenetic variation on phenytoin prescribing practice and patient response in an integrated health system
Variation in genes controlling warfarin disposition and response in American Indian and Alaska Native people
Genetics, Diet, and Season Are Associated with Serum 25-Hydroxycholecalciferol Concentration in a Yup’ik Study Population from Southwestern Alaska